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ScienceDirectNatural IgM are crucial for early protection against infection and
play an important homeostatic function by clearing dead cells.
The production of IgM is ensured by a population of B cells with
innate-like properties: their response is rapidly activated by
innate signals early during the onset of infection. The main
reservoir of innate-like B cells (IBCs) are the serous cavities, but
their maintenance and activation depends on their relocation to
a variety of lymphoid tissues. Recent advances indicate that
fat-associated lymphoid clusters (FALCs) and milky spots
contribute to local IgM secretion and play a central role in the
localisation and regulation of IBC function.
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Introduction
IBCs are characterised by a poly-specific BCR repertoire
enriched for receptors that bind microbial and self-anti-
gens and are responsible for the majority of circulating
IgM in uninfected animals. These so called ‘natural’ IgM
form pentamers with high neutralisation and complement
activation capacity [1]. Self-reactivity and the capacity to
be promptly activated following innate stimulation by
Toll-like receptor (TLR) agonists and microbial patho-
gens confers to these B cell subsets an important role in
tissue homeostasis and host protection [1]. The main IBC
compartment is composed of the B cells of the serous
cavities, represented by CD11b expressing B1 cells,
divided into two main subsets B1a and B1b based on
their expression of CD5, and a minority of serous B2 cells
that do not express CD11b.
Paradoxically, serous IBCs cannot secrete IgM [2] and
rely on various homing mechanisms to find a lymphoidwww.sciencedirect.com niche enabling secretion of IgM. Their capacity to
migrate to different locations depending on the immune
context, ensures production of IgM in the relevant com-
partment. Indeed, IgM is a large molecule and as such,
secretion into the circulation does not guarantee efficacy
at sites of infection. In this review, we will discuss the
mechanisms controlling the re-location of serous B cells to
local lymphoid niches for the secretion of protective IgM
and the emerging importance of FALCs and milky spots
for IBC immune function.
FALCs and milky spots are essential for the
maintenance and function of IBCs in serous
cavities
FALCs and milky spots: homeostatic niches for the
maintenance of IBCs in serous cavities
The fluid filled phase of the serous cavities plays an
important lubricative function for the visceral organs,
and is home to various immune cell populations including
macrophages [3], T-cells and IBCs [4]. Serous IBCs are as
dependent on the existence of a homeostatic niche for
their maintenance and activation as conventional B cells.
In the serous cavities, this niche is provided by small
immune aggregates found in various visceral adipose
tissues [5,6]. These aggregates were first identified in
the omentum, a large apron-like adipose tissue covering
the viscera in humans and called milky spots, because of
their visible milky appearance. Existence of similar struc-
tures called FALCs was then reported in the mesenteries
[7], the mediastinum and pericardium of mice [8].
These structures produce the chemotactic B cell factor
CXCL13, which is critical for the maintenance of B cells
in serous cavities [8,9–11]. Interestingly, all IBCs
express the atypical chemokine receptor D6, which
seems to fine-tune CXCL13 responsiveness and control
IBC homing and anti-Phosphorylcholine antibody gener-
ation [12]. The fact that CXCL13 is required to maintain
a normal number of IBCs in serous cavities [9] and that
after intra-pleural injection, a fraction of pleural cavity B
cells spontaneously home to FALCs [13], suggests that
continuous recirculation to FALCs and milky spots is
necessary for IBC homeostasis. To stay in serous cavities,
IBCs express very high levels of a4, a6 and b1 integrins as
well as CD9 [10], which enable their adherence to the
parietal and visceral mesothelium of the serous cavity.
Upon TLR stimulation, down-regulation of the surface
expression of these molecules induces increased mobility
of IBCs and egress from peritoneal cavity toward
CXCL13 producing clusters in the omentum, mesenter-
ies and spleen [10].Current Opinion in Immunology 2018, 50:9–13
10 Innate immunityFALCs and milky spots are a local source of IL-33 and
IL-5 for IBC activation in serous cavities
Studies by Moro et al. and in our lab identify two key
factors secreted by FALCs and milky spots necessary for
IBC activation: the cytokine IL-5 produced by type
2 innate lymphoid cells (ILC2) [7] and the nuclear
alarmin IL-33 produced by Gp38+CD31 FALC stromal
cells [13]. IL-5 is a crucial factor for the maintenance
and activation of IBC [14], which is produced by FALC
ILC2 both at homeostasis to ensure self-renewal [7]
and upon immune challenge to allow proliferation and
antibody secretion of serous B1 and B2 cells [13]. IL-33
is likely to link inflammation, ILC2 activation, IL-5
release and IBC activation. What controls the release
of IL-33 by FALC stromal cells is not understood but it
is clear that IL-33 function is limited in time and space
by its rapid inactivation by oxidation [15] and that FALC
provide an IL-33 rich environment bringing together
ILC2 and IBCs. Whether this is important for the
maintenance of basal ILC2 and IBC numbers remains
to be clarified.
FALCs and milky spots allow production of IgM for
protection of serous cavities
Activation of IBCs in the omentum, mediastinum and
pericardium leads to secretion of poly-reactive IgM in
the peritoneal, pleural/pericardial cavities, which does
not diffuse away from the cavity of origin and protects
the serous cavity locally. This is exemplified in the
model of filarial infection Litomosoides sigmodontis
which resides between the pleural membranes of its
murine host. The presence of this worm activates
FALCs within the pericardium and mediastinum to
secrete large amounts of IgM that can be detected
within the pleural (site of infection) but not the peri-
toneal (separate compartment) lavage fluid [13].
Importantly this locally produced antibody is not
detectable in the lavage fluid of naı¨ve animals, nor is
it detectable in the serum during the innate phase of
this infection [13]. The inability to detect such a
response in the serum highlights a deficit in many of
the studies to date that attempt to address the contri-
bution of serous B-cells to innate antibody production
but fail to look locally within the serous cavities.
Secreted IgM is unquestionably important for protec-
tion following infection within the peritoneal cavity as
shown by studies in mice that lack secreted IgM. Worm
survival is enhanced in animals infected with the filarial
nematode Brugia malayi in the absence of secreted IgM
[16]. Survival of animals that lack secreted IgM is
reduced in a model of peritonitis induced by cecal
ligation and puncture, in which intestinal contents
(bacteria) are released into the peritoneal cavity [17].
Using splenectomised mice, a recent study confirmed
the importance of the omentum as a site of IgM pro-
duction for protection from intraperitoneal bacterial
infection [18]. Within the peritoneal cavity, naturalCurrent Opinion in Immunology 2018, 50:9–13 IgM works in concert with macrophages and comple-
ment to neutralise pathogens (worms and bacteria
alike), limiting their systemic spread.
Serous B-cell relocation: getting secretion of
IgM in the right compartment
The spleen and bone marrow (BM): secretion of natural
IgM into the blood
B1 cells produce 80–90% of the total serum IgM pool in
uninfected mice [19], which is crucial for limiting the
early spread of infection and for protection against a
number of pathogens [1]. The spleen and BM, while
only hosting a small proportion of B1 cells compared to
the serous cavities, are the main producers of basal
serum IgM [20–26]. A recent study revealed the exis-
tence of two main subsets of IgM secreting B1 cells in
the spleen and BM: one dependent on B lymphocyte-
induced maturation protein 1 (Blimp-1) and terminal
differentiation into CD138+ plasma cells and one inde-
pendent of Blimp-1 [24]. When migrating to the spleen,
peritoneal B1a cells gain the expression of CD6, which is
required for self-renewal of this population in the spleen
[27]. Studies in splenectomised and asplenic mice confirm
the importance of the spleen for supporting the production
of serum IgM and for maintaining the B1a cell pool in the
peritoneal cavity [28,29]. However, it is unclear whether
peritoneal B1 cells are dependent on a splenic precursor for
their maintenance or are indirectly affected by reduced
serum IgM levels in splenectomised mice. Conversely,
upon infection, peritoneal cavity B1 cells migrate to the
spleen in response to TLR activation, which allows
increased secretion of poly-reactive IgM into the circula-
tion at early stages of infection [10,26] to limit the spread of
blood-borne pathogens [30] and the risk of sepsis during
peritonitis [17].
During bacterial infection and in response to TLR4 activa-
tion by LPS, peritoneal B1a cells can also give rise to a
distinct IBC subset, called Innate Response Activator (IRA)
B cells. IRA B cells migrate to the splenic red pulp using
VLA-4, where they produce granulocyte/macrophage col-
ony stimulating factor (GM-CSF) which by binding the
common g-chain of the GM-CSF receptor, common to
GM-CSF, IL-3 and IL-5 receptors, increases the secretion
of IgM in an autocrine loop, limiting bacterial dissemination
and preventing sepsis [31]. Considering that the secretion
of IgM by IBCs in FALCs was highly dependent on IL-5
[13] raises the question of whether IL-5 is required for IRA
B cell activation or whether the autocrine GM-CSF loop is a
way to licence IgM secretion by B1 cells independently
of IL-5 producing cells. The requirement for either IL-5 or
GM-CSF may be entirely dependent upon the context of
the inflammatory stimulus with type 2 inflammation result-
ing in IL-5 secretion as compared to a type-1 inflammatory
situation (such as sepsis) requiring GM-CSF. In support of
this concept, blockade of GM-CSF does not limit thewww.sciencedirect.com
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exposed mice (Benezech lab, unpublished data).
The gut: secretion of IgM and IgA at the lamina propria
Naı¨ve B-cells do not generally gain entry to the small
intestine, however, peritoneal B1 cells and transferred B-
cells that have trafficked through the peritoneal cavity
have the capacity to migrate into this site to become IgM
and IgA secreting plasma cells [10,32,33]. The production
of mucosal antibodies in the intestine by IBCs is depen-
dent on the presence of commensal bacteria [34].
Retinoic acid (RA) is a key factor for the gut homing of
IgA producing B cells [35]. In the peritoneal cavity, RA isFigure 1
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GATA6 induction in peritoneal macrophages and their
localisation and functional polarisation in the peritoneal
cavity [36]. In particular, GATA6 controls the secretion
of TGF-b2 by peritoneal macrophages which is required
for IgA secretion by IBCs at the lamina propria [36]. RA
can also directly potentiate peritoneal B1b cells IgA class-
switching [37] and is directly important for the mainte-
nance and function of B1 cells [32,38] through the control
of the expression of the nuclear factor of activated T cells
c1 (NFATc1) in B1 cells [32]. This suggests that RA
production by omental cells is a central regulatory mech-
anism of IBC function in the peritoneal cavity and at the
gut barrier (Figure 1).s
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12 Innate immunityThe airways: secretion of IgM in the mediastinal lymph
nodes and lung
IBCs and natural IgM are important for protection
against viral and bacterial infection of the airways. In
general, the contribution of pleural IBCs has been less
studied than peritoneal IBCs and the mechanisms lead-
ing to secretion of natural IgM or IBC derived IgA in the
airways and lung tissue are less clear. However, two
distinct mechanisms have emerged, involving accumu-
lation of B1a cells in the draining lymph nodes or
relocation to the lung parenchyma.
Following respiratory tract infection with influenza virus,
pleural B1a cells migrate to the draining lymph nodes and
contribute to the secretion of protective poly-reactive
neutralising IgM against the virus, limiting viral load in
the respiratory tract [39,40,41]. Accumulation of B1a
cells in regional lymph nodes is induced by type I IFNR
signalling which activates CD11b to form a high affinity
state and mediates the transfer of B1a cells across the
blood/lymphatic endothelium [41]. Interestingly, after
migration to the lymph nodes [41] and spleen [26], the
expression of CD11b is downregulated. It is therefore
possible that CD11b expression by IBCs in serous cavities
is a pre-requisite for their relocation from serous cavities
into secondary lymphoid organs. Work in our lab indicates
that upon influenza infection, IBCs also home to medias-
tinal and pericardial FALCs where they proliferate and
secrete IgM (Benezech lab, unpublished). The relative
importance of FALCs and regional LNs for IBC function
in influenza will need to be clarified.
During pneumonia, pleural B1a cells give rise to IRA-B
cells that migrate to the lung parenchyma and secrete
poly-reactive IgM via autocrine GM-CSF signalling [42].
Whether IRA-B cell function during pneumonia is inde-
pendent of mediastinal and pericardial FALCs or require
these structures for their migration or to complete their
activation is not known.
Future perspectives
Although it has become apparent that the peritoneal and
pleural cavities provide an important layer of immune
surveillance supporting immunity at the gut and lung
mucosa, the immune function of the pericardial cavity
remains elusive. The omentum is emerging as an impor-
tant platform linking peritoneal cavity and gut immunity
but there is still evident deficit of experimental studies
investigating IBCs of both the pleural and pericardial
cavities. The exact contribution of mediastinal and peri-
cardial FALCs to lung immunity needs to be further
explored. There are obvious reasons why the pericardial
cavity has been less studied — the murine pericardial
cavity is small and experimentally inaccessible. The
presence of FALCs in the peri-aortic area of atheroscle-
rotic animals and the importance of IL-5 secreting ILC2
for protection has also been recently reported [43]. B1Current Opinion in Immunology 2018, 50:9–13 cells and natural IgM (recognising oxidation specific
epitopes) are known to be protective [44] and clinical
studies show that lower levels of IgM correlate with
increased risk of cardiovascular disease [45,46]. It is
therefore important that we start investigating the role
of pericardial and peri-aortic FALCs in cardiovascular
disease.
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